Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery (original) (raw)

• Chylinski, K., Makarova, K.S., Charpentier, E. & Koonin, E.V. Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res. 42, 6091–6105 (2014).
  CAS PubMed PubMed Central Google Scholar
• Makarova, K.S. et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13, 722–736 (2015).
  CAS PubMed PubMed Central Google Scholar
• Sontheimer, E.J. & Barrangou, R. The bacterial origins of the CRISPR genome-editing revolution. Hum. Gene Ther. 26, 413–424 (2015).
  CAS PubMed Google Scholar
• Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).This study describes the minimal components required to program a type II CRISPR-Cas9 system for targeted DNA cleavage in vitro and demonstrates that crRNA and tracrRNA can be joined into an sgRNA to generate a two-component system for site-specific editing.
  Article CAS PubMed PubMed Central Google Scholar
• Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S. & Gregory, P.D. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11, 636–646 (2010).
  CAS PubMed Google Scholar
• Joung, J.K. & Sander, J.D. TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14, 49–55 (2013).
  CAS PubMed Google Scholar
• Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).This is one of the first studies to demonstrate that the type II CRISPR-Cas9 system can be programmed to generate DSBs in mammalian cells. This study demonstrated that multiple guides can be used to program cleavage or nicking at more than one sequence in a genome within a cell.
  CAS PubMed PubMed Central Google Scholar
• Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).This is one of the first studies to demonstrate that the type II CRISPR-Cas9 system can be programmed to generate DSBs in a variety of mammalian cell types, including induced pluripotent stem cells. This study also demonstrated HDR-mediated insertion of exogenous DNA sequences using Cas9-induced DSBs or nicks.
  CAS PubMed PubMed Central Google Scholar
• Cho, S.W., Kim, S., Kim, J.M. & Kim, J.-S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230–232 (2013).This is one of the first studies to demonstrate that the type II CRISPR-Cas9 system can be programmed to generate DSBs in a variety of mammalian cell types.
  CAS PubMed Google Scholar
• Jinek, M. et al. RNA-programmed genome editing in human cells. Elife 2, e00471 (2013).This is one of the first studies to demonstrate that the type II CRISPR-Cas9 system can be programmed to generate DSBs in mammalian cells.
  Article PubMed PubMed Central Google Scholar
• Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910–918 (2013).This study reports a rapid strategy for generating knockout mouse models using multiplex gene editing, in which two genes can be targeted simultaneously to generate carriers containing dual gene disruptions or ssODNs can be included to create HDR-mediated knock-ins at two different loci.
  CAS PubMed PubMed Central Google Scholar
• Hwang, W.Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31, 227–229 (2013).This study demonstrated that the type II CRISPR-Cas9 system can be used in a vertebrate organism to successfully inactivate target genes.
  CAS PubMed PubMed Central Google Scholar
• Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479–1491 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ledford, H. CRISPR, the disruptor. Nature 522, 20–24 (2015).
  CAS PubMed Google Scholar
• Doudna, J.A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).
  PubMed Google Scholar
• Cox, D.B.T., Platt, R.J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121–131 (2015).
  CAS PubMed PubMed Central Google Scholar
• Jao, L.-E., Wente, S.R. & Chen, W. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci. USA 110, 13904–13909 (2013).
  CAS PubMed PubMed Central Google Scholar
• Swiech, L. et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat. Biotechnol. 33, 102–106 (2015).
  CAS PubMed Google Scholar
• Kabadi, A.M., Ousterout, D.G., Hilton, I.B. & Gersbach, C.A. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Res. 42, e147 (2014).
  PubMed PubMed Central Google Scholar
• Mandal, P.K. et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell 15, 643–652 (2014).
  CAS PubMed PubMed Central Google Scholar
• Tsai, S.Q. et al. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat. Biotechnol. 32, 569–576 (2014).
  CAS PubMed PubMed Central Google Scholar
• Hendel, A. et al. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat. Biotechnol. 33, 985–989 (2015).
  CAS PubMed PubMed Central Google Scholar
• Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 1370–1379 (2013).
  CAS PubMed PubMed Central Google Scholar
• Canver, M.C. et al. Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. J. Biol. Chem. 289, 21312–21324 (2014).
  PubMed PubMed Central Google Scholar
• Lupiáñez, D.G. et al. Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell 161, 1012–1025 (2015).
  PubMed PubMed Central Google Scholar
• Torres, R. et al. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat. Commun. 5, 3964 (2014).
  CAS PubMed Google Scholar
• Choi, P.S. & Meyerson, M. Targeted genomic rearrangements using CRISPR/Cas technology. Nat. Commun. 5, 3728 (2014).
  CAS PubMed Google Scholar
• Ghezraoui, H. et al. Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol. Cell 55, 829–842 (2014).
  CAS PubMed PubMed Central Google Scholar
• Cho, S.W. et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res. 24, 132–141 (2014).
  CAS PubMed PubMed Central Google Scholar
• Wang, T., Wei, J.J., Sabatini, D.M. & Lander, E.S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80–84 (2014).
  CAS PubMed Google Scholar
• Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87 (2014).
  CAS PubMed Google Scholar
• Koike-Yusa, H., Li, Y., Tan, E.-P., Velasco-Herrera, M.D.C. & Yusa, K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267–273 (2014).
  CAS PubMed Google Scholar
• Zhou, Y. et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 509, 487–491 (2014).
  CAS PubMed Google Scholar
• Platt, R.J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440–455 (2014).
  CAS PubMed PubMed Central Google Scholar
• Parnas, O. et al. A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks. Cell 162, 675–686 (2015).
  CAS PubMed PubMed Central Google Scholar
• Byrne, S.M., Ortiz, L., Mali, P., Aach, J. & Church, G.M. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. 43, e21 (2015).
  PubMed Google Scholar
• Yang, L. et al. Optimization of scarless human stem cell genome editing. Nucleic Acids Res. 41, 9049–9061 (2013).
  CAS PubMed PubMed Central Google Scholar
• Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551–553 (2014).
  CAS PubMed PubMed Central Google Scholar
• Schumann, K. et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc. Natl. Acad. Sci. USA 112, 10437–10442 (2015).
  CAS PubMed PubMed Central Google Scholar
• Lin, S., Staahl, B.T., Alla, R.K. & Doudna, J.A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife 3, e04766 (2014).
  PubMed PubMed Central Google Scholar
• Holkers, M. et al. Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat. Methods 11, 1051–1057 (2014).
  CAS PubMed Google Scholar
• Kaulich, M. et al. Efficient CRISPR-rAAV engineering of endogenous genes to study protein function by allele-specific RNAi. Nucleic Acids Res. 43, e45 (2015).
  PubMed PubMed Central Google Scholar
• Hendel, A. et al. Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing. Cell Rep. 7, 293–305 (2014).
  CAS PubMed PubMed Central Google Scholar
• Chu, V.T. et al. Increasing the efficiency of homology-directed repair for CRISPR-Cas9–induced precise gene editing in mammalian cells. Nat. Biotechnol. 33, 543–548 (2015).
  CAS PubMed Google Scholar
• Maruyama, T. et al. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat. Biotechnol. 33, 538–542 (2015).
  CAS PubMed PubMed Central Google Scholar
• Sánchez-Rivera, F.J. et al. Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature 516, 428–431 (2014).
  PubMed PubMed Central Google Scholar
• Xue, W. et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 514, 380–384 (2014).
  CAS PubMed PubMed Central Google Scholar
• Chen, Y. et al. Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9. Hum. Mol. Genet. 24, 3764–3774 (2015).
  CAS PubMed PubMed Central Google Scholar
• Ablain, J., Durand, E.M., Yang, S., Zhou, Y. & Zon, L.I.A. CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish. Dev. Cell 32, 756–764 (2015).
  CAS PubMed PubMed Central Google Scholar
• Wang, D. et al. Adenovirus-mediated somatic genome editing of Pten by CRISPR/Cas9 in mouse liver in spite of Cas9-specific immune responses. Hum. Gene Ther. 26, 432–442 (2015).
  CAS PubMed PubMed Central Google Scholar
• Zuckermann, M. et al. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat. Commun. 6, 7391 (2015).
  CAS PubMed Google Scholar
• Sánchez-Rivera, F.J. & Jacks, T. Applications of the CRISPR-Cas9 system in cancer biology. Nat. Rev. Cancer 15, 387–395 (2015).
  PubMed PubMed Central Google Scholar
• Wang, G. et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 20, 616–623 (2014).
  CAS PubMed PubMed Central Google Scholar
• Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246–1260 (2015).
  CAS PubMed PubMed Central Google Scholar
• Maddalo, D. et al. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 516, 423–427 (2014).
  CAS PubMed PubMed Central Google Scholar
• Blasco, R.B. et al. Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology. Cell Rep. 9, 1219–1227 (2014).
  CAS PubMed Google Scholar
• Gersbach, C.A. Technologies and applications for programmable gene regulation and epigenome editing. Nat. Methods (in the press).
• Li, H.L. et al. Precise correction of the dystrophin gene in Duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Reports 4, 143–154 (2015).
  CAS PubMed Google Scholar
• Park, C.-Y. et al. Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9. Cell Stem Cell 17, 213–220 (2015).
  CAS PubMed Google Scholar
• Gori, J.L. et al. Delivery and specificity of CRISPR-Cas9 genome editing technologies for human gene therapy. Hum. Gene Ther. 26, 443–451 (2015).
  CAS PubMed Google Scholar
• Wu, Z., Yang, H. & Colosi, P. Effect of genome size on AAV vector packaging. Mol. Ther. 18, 80–86 (2010).
  CAS PubMed Google Scholar
• Hou, Z. et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 110, 15644–15649 (2013).
  CAS PubMed PubMed Central Google Scholar
• Zhang, Y. et al. Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis. Mol. Cell 50, 488–503 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ran, F.A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186–191 (2015).This study defined the critical components required for efficient DSB formation by the compact type II-A S. aureus Cas9. S. aureus Cas9 and its sgRNA were packaged in a single AAV, which permitted efficient in vivo genome editing in mouse liver.
  CAS PubMed PubMed Central Google Scholar
• Hacein-Bey-Abina, S. et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132–3142 (2008).
  CAS PubMed PubMed Central Google Scholar
• Stein, S. et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat. Med. 16, 198–204 (2010).
  CAS PubMed Google Scholar
• Sternberg, S.H., Redding, S., Jinek, M., Greene, E.C. & Doudna, J.A. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507, 62–67 (2014).This in vitro study combined single-molecule analysis and biochemical assays to provide mechanistic insights into Cas9-sgRNA–mediated DNA recognition and cleavage.
  CAS PubMed PubMed Central Google Scholar
• Szczelkun, M.D. et al. Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes. Proc. Natl. Acad. Sci. USA 111, 9798–9803 (2014).
  CAS PubMed PubMed Central Google Scholar
• Wu, X. et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 32, 670–676 (2014).
  CAS PubMed PubMed Central Google Scholar
• Anders, C., Niewoehner, O., Duerst, A. & Jinek, M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513, 569–573 (2014).This co-crystal structure of the SpCas9-sgRNA-target DNA complex defined the critical residues involved in PAM recognition by SpCas9.
  CAS PubMed PubMed Central Google Scholar
• Jinek, M. et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343, 1247997 (2014).
  PubMed PubMed Central Google Scholar
• Nishimasu, H. et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156, 935–949 (2014).This co-crystal structure of the SpCas9-sgRNA-target DNA complex provided the first high-resolution picture of guide-target heteroduplex formation in the context of SpCas9 recognition.
  CAS PubMed PubMed Central Google Scholar
• Jiang, F., Zhou, K., Ma, L., Gressel, S. & Doudna, J.A. A Cas9–guide RNA complex preorganized for target DNA recognition. Science 348, 1477–1481 (2015).
  CAS PubMed Google Scholar
• Hsu, P.D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–832 (2013).This study was one of the first to systematically evaluate the potential for SpCas9 to tolerate mismatches between the guide sequence and near-cognate genomic sequences. It demonstrated that multiple mismatches can be tolerated at some loci.
  CAS PubMed PubMed Central Google Scholar
• Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822–826 (2013).This study was one of the first to systematically evaluate the potential for SpCas9 to tolerate mismatches between the guide sequence and near-cognate genomic sequences. It demonstrated that for some guides, up to five mismatches can be tolerated.
  CAS PubMed PubMed Central Google Scholar
• Chari, R., Mali, P., Moosburner, M. & Church, G.M. Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach. Nat. Methods 12, 823–826 (2015).
  CAS PubMed PubMed Central Google Scholar
• Kuscu, C., Arslan, S., Singh, R., Thorpe, J. & Adli, M. Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat. Biotechnol. 32, 677–683 (2014).
  CAS PubMed Google Scholar
• Zhang, Y. et al. Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells. Sci. Rep. 4, 5405 (2014).
  PubMed PubMed Central Google Scholar
• Mali, P. et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31, 833–838 (2013).
  CAS PubMed PubMed Central Google Scholar
• Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA 109, E2579–E2586 (2012).
  CAS PubMed PubMed Central Google Scholar
• Gagnon, J.A. et al. Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs. PLoS ONE 9, e98186 (2014).
  PubMed PubMed Central Google Scholar
• Doench, J.G. et al. Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation. Nat. Biotechnol. 32, 1262–1267 (2014).
  CAS PubMed PubMed Central Google Scholar
• Farboud, B. & Meyer, B.J. Dramatic enhancement of genome editing by CRISPR/Cas9 through improved guide RNA design. Genetics 199, 959–971 (2015).
  CAS PubMed PubMed Central Google Scholar
• Xu, H. et al. Sequence determinants of improved CRISPR sgRNA design. Genome Res. 25, 1147–1157 (2015).
  CAS PubMed PubMed Central Google Scholar
• Montague, T.G., Cruz, J.M., Gagnon, J.A., Church, G.M. & Valen, E. CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res. 42, W401–W407 (2014).
  CAS PubMed PubMed Central Google Scholar
• Moreno-Mateos, M.A. et al. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat. Methods 12, 982–988 (2015).
  CAS PubMed PubMed Central Google Scholar
• Pattanayak, V. et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31, 839–843 (2013).
  CAS PubMed PubMed Central Google Scholar
• Lin, Y. et al. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res. 42, 7473–7485 (2014).
  CAS PubMed PubMed Central Google Scholar
• Smith, C. et al. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell 15, 12–13 (2014).
  CAS PubMed PubMed Central Google Scholar
• Veres, A. et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell 15, 27–30 (2014).
  CAS PubMed PubMed Central Google Scholar
• Kim, D. et al. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat. Methods 12, 237–243 (2015).
  CAS PubMed Google Scholar
• Tsai, S.Q. & Joung, J.K. What's changed with genome editing? Cell Stem Cell 15, 3–4 (2014).
  CAS PubMed Google Scholar
• Iyer, V. et al. Off-target mutations are rare in Cas9-modified mice. Nat. Methods 12, 479 (2015).
  CAS PubMed Google Scholar
• Shen, B. et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat. Methods 11, 399–402 (2014).
  CAS PubMed Google Scholar
• Varshney, G.K. et al. High-throughput gene targeting and phenotyping in zebrafish using CRISPR/Cas9. Genome Res. 25, 1030–1042 (2015).
  CAS PubMed PubMed Central Google Scholar
• Zhu, L.J., Holmes, B.R., Aronin, N. & Brodsky, M.H. CRISPRseek: a Bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems. PLoS ONE 9, e108424 (2014).
  PubMed PubMed Central Google Scholar
• Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473–1475 (2014).
  CAS PubMed PubMed Central Google Scholar
• Cradick, T.J., Qiu, P., Lee, C.M., Fine, E.J. & Bao, G. COSMID: a web-based tool for identifying and validating CRISPR/Cas off-target sites. Mol. Ther. Nucleic Acids 3, e214 (2014).
  CAS PubMed PubMed Central Google Scholar
• Singh, R., Kuscu, C., Quinlan, A., Qi, Y. & Adli, M. Cas9-chromatin binding information enables more accurate CRISPR off-target prediction. Nucleic Acids Res. 43, e118 (2015).
  PubMed PubMed Central Google Scholar
• Aach, J., Mali, P. & Church, G.M. CasFinder: flexible algorithm for identifying specific Cas9 targets in genomes. bioRxiv doi:10.1101/005074 (2014).
• Heigwer, F., Kerr, G. & Boutros, M. E-CRISP: fast CRISPR target site identification. Nat. Methods 11, 122–123 (2014).
  CAS PubMed Google Scholar
• Sander, J.D. et al. ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool. Nucleic Acids Res. 38, W462–W468 (2010).
  CAS PubMed PubMed Central Google Scholar
• Xiao, A. et al. CasOT: a genome-wide Cas9/gRNA off-target searching tool. Bioinformatics 30, 1180–1182 (2014).
  CAS PubMed Google Scholar
• Tsai, S.Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187–197 (2015).
  CAS PubMed Google Scholar
• Frock, R.L. et al. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol. 33, 179–186 (2015).
  CAS PubMed Google Scholar
• Wang, X. et al. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat. Biotechnol. 33, 175–178 (2015).
  CAS PubMed Google Scholar
• Crosetto, N. et al. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat. Methods 10, 361–365 (2013).
  CAS PubMed PubMed Central Google Scholar
• Gabriel, R. et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol. 29, 816–823 (2011).
  CAS PubMed Google Scholar
• Fu, Y., Sander, J.D., Reyon, D., Cascio, V.M. & Joung, J.K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32, 279–284 (2014).
  CAS PubMed PubMed Central Google Scholar
• Kim, S., Kim, D., Cho, S.W., Kim, J. & Kim, J.-S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 24, 1012–1019 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ramakrishna, S. et al. Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res. 24, 1020–1027 (2014).
  CAS PubMed PubMed Central Google Scholar
• D'Astolfo, D.S. et al. Efficient intracellular delivery of native proteins. Cell 161, 674–690 (2015).
  CAS PubMed Google Scholar
• Zuris, J.A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73–80 (2015).
  CAS PubMed Google Scholar
• Ran, F.A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380–1389 (2013).
  CAS PubMed PubMed Central Google Scholar
• Wyvekens, N., Topkar, V.V., Khayter, C., Joung, J.K. & Tsai, S.Q. Dimeric CRISPR RNA-guided FokI-dCas9 nucleases directed by truncated gRNAs for highly specific genome editing. Hum. Gene Ther. 26, 425–431 (2015).
  CAS PubMed PubMed Central Google Scholar
• Guilinger, J.P., Thompson, D.B. & Liu, D.R. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat. Biotechnol. 32, 577–582 (2014).
  CAS PubMed PubMed Central Google Scholar
• Kleinstiver, B.P. et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523, 481–485 (2015).
  PubMed PubMed Central Google Scholar
• Bolukbasi, M.F. et al. DNA-binding-domain fusions enhance the targeting range and precision of Cas9. Nat. Methods doi:10.1038/nmeth.3624 (19 October 2015).
• Wright, A.V. et al. Rational design of a split-Cas9 enzyme complex. Proc. Natl. Acad. Sci. USA 112, 2984–2989 (2015).
  CAS PubMed PubMed Central Google Scholar
• Zetsche, B., Volz, S.E. & Zhang, F. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat. Biotechnol. 33, 139–142 (2015).
  CAS PubMed Google Scholar
• Nihongaki, Y., Kawano, F., Nakajima, T. & Sato, M. Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat. Biotechnol. 33, 755–760 (2015).
  CAS PubMed Google Scholar
• Truong, D.-J.J. et al. Development of an intein-mediated split-Cas9 system for gene therapy. Nucleic Acids Res. 43, 6450–6458 (2015).
  CAS PubMed PubMed Central Google Scholar
• Davis, K.M., Pattanayak, V., Thompson, D.B., Zuris, J.A. & Liu, D.R. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat. Chem. Biol. 11, 316–318 (2015).
  CAS PubMed PubMed Central Google Scholar
• Fonfara, I. et al. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res. 42, 2577–2590 (2014).
  CAS PubMed Google Scholar
• Esvelt, K.M. et al. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 10, 1116–1121 (2013).
  CAS PubMed PubMed Central Google Scholar
• Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759–771 (2015).
  CAS PubMed PubMed Central Google Scholar
• Hendel, A., Fine, E.J., Bao, G. & Porteus, M.H. Quantifying on- and off-target genome editing. Trends Biotechnol. 33, 132–140 (2015).
  CAS PubMed PubMed Central Google Scholar
• Shi, J. et al. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat. Biotechnol. 33, 661–667 (2015).
  CAS PubMed PubMed Central Google Scholar
• Kok, F.O. et al. Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. Dev. Cell 32, 97–108 (2015).
  CAS PubMed Google Scholar
• Xiao, A. et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res. 41, e141 (2013).
  CAS PubMed PubMed Central Google Scholar
• Han, J. et al. Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9. RNA Biol. 11, 829–835 (2014).
  CAS PubMed PubMed Central Google Scholar
• Wang, S., Sengel, C., Emerson, M.M. & Cepko, C.L. A gene regulatory network controls the binary fate decision of rod and bipolar cells in the vertebrate retina. Dev. Cell 30, 513–527 (2014).
  PubMed PubMed Central Google Scholar
• Chen, S. et al. Global microRNA depletion suppresses tumor angiogenesis. Genes Dev. 28, 1054–1067 (2014).
  CAS PubMed PubMed Central Google Scholar
• Hnisz, D. et al. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol. Cell 58, 362–370 (2015).
  CAS PubMed PubMed Central Google Scholar
• Bedell, V.M. et al. In vivo genome editing using a high-efficiency TALEN system. Nature 491, 114–118 (2012).
  CAS PubMed PubMed Central Google Scholar
• Hwang, W.Y. et al. Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS ONE 8, e68708 (2013).
  CAS PubMed PubMed Central Google Scholar
• Sharma, R. et al. In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126, 1777–1784 (2015).
  CAS PubMed PubMed Central Google Scholar
• Schmidt, M. et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100, 2737–2743 (2002).
  CAS PubMed Google Scholar
• Chiarle, R. et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 147, 107–119 (2011).
  CAS PubMed PubMed Central Google Scholar
• Josephs, E.A. et al. Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage. Nucleic Acids Res. 43, 8924–8941 (2015).
  CAS PubMed PubMed Central Google Scholar